BACKGROUND: Metabolic syndrome is prevalent in adults characterized by increased visceral adiposity and insulin resistance (IR). However, the link between pancreatic β-cell function and metabolic syndrome severity in adults across the glucose spectrum is unknown. We hypothesized that poor β-cell function would independently predict a higher metabolic syndrome Z-score (i.e., severity). METHODS: Seventy (12 normal glucose tolerant, 37 prediabetic, 21 type 2 diabetic) obese adults [62.4±1.1 year; 34.6±0.6 kg/m(2); data are mean±standard error of the mean (SEM)] participated in this cross-sectional study. A 2-hr 75-gram oral glucose tolerance test (OGTT) was administered, and insulin and glucose area under the curve was determined for calculations of insulin action. Fasting and glucose-stimulated insulin secretion was calculated using homeostasis model assessment of insulin secretion (HOMA-B) and the insulinogenic index (i.e., I(0-30)/Glc(0-30) or I(60-120)/Glc(60-120)), respectively. Fasting and postprandial insulin sensitivity was assessed by HOMA-IR and the Matsuda Index, respectively. β-cell function was estimated using the disposition index via HOMA-B/HOMA-IR, I(0-30)/Glc(0-30) or I(60-120)/Glc(60-120) × Matsuda Index, which represents basal, first-, and second-phase insulin release, respectively. Body composition (via computerized tomography and dual X-ray absorptiometry) and sex-specific metabolic syndrome Z-scores were calculated from waist circumference, blood pressure, fasting glucose, triglycerides, and high-density lipoproteins. RESULTS: Compared to those with normal glucose tolerance, visceral fat and IR were higher and β-cell function was lower in adults with glucose intolerance and type 2 diabetes mellitus. Elevated visceral fat and IR (HOMA-IR and Matsuda Index) correlated with elevated Z-scores (r=0.51, r=0.54, r=-0.49; all P<0.002, respectively). Basal, first-, and second-phase β-cell function correlated with low Z-scores (r=-0.59, r=-0.51, and r=-0.43, all P<0.001). Insulin secretion significantly predicted the Z-score independent of sex, body fat, blood lipids, blood pressure, IR, and glucose metabolism (P<0.005). CONCLUSION: β-cell dysfunction is highly correlated with the severity of metabolic syndrome in adults. Future work is warranted to elucidate the mechanism by which cardiometabolic disturbances influence insulin secretion.
BACKGROUND:Metabolic syndrome is prevalent in adults characterized by increased visceral adiposity and insulin resistance (IR). However, the link between pancreatic β-cell function and metabolic syndrome severity in adults across the glucose spectrum is unknown. We hypothesized that poor β-cell function would independently predict a higher metabolic syndrome Z-score (i.e., severity). METHODS: Seventy (12 normal glucose tolerant, 37 prediabetic, 21 type 2 diabetic) obese adults [62.4±1.1 year; 34.6±0.6 kg/m(2); data are mean±standard error of the mean (SEM)] participated in this cross-sectional study. A 2-hr 75-gram oral glucose tolerance test (OGTT) was administered, and insulin and glucose area under the curve was determined for calculations of insulin action. Fasting and glucose-stimulated insulin secretion was calculated using homeostasis model assessment of insulin secretion (HOMA-B) and the insulinogenic index (i.e., I(0-30)/Glc(0-30) or I(60-120)/Glc(60-120)), respectively. Fasting and postprandial insulin sensitivity was assessed by HOMA-IR and the Matsuda Index, respectively. β-cell function was estimated using the disposition index via HOMA-B/HOMA-IR, I(0-30)/Glc(0-30) or I(60-120)/Glc(60-120) × Matsuda Index, which represents basal, first-, and second-phase insulin release, respectively. Body composition (via computerized tomography and dual X-ray absorptiometry) and sex-specific metabolic syndrome Z-scores were calculated from waist circumference, blood pressure, fasting glucose, triglycerides, and high-density lipoproteins. RESULTS: Compared to those with normal glucose tolerance, visceral fat and IR were higher and β-cell function was lower in adults with glucose intolerance and type 2 diabetes mellitus. Elevated visceral fat and IR (HOMA-IR and Matsuda Index) correlated with elevated Z-scores (r=0.51, r=0.54, r=-0.49; all P<0.002, respectively). Basal, first-, and second-phase β-cell function correlated with low Z-scores (r=-0.59, r=-0.51, and r=-0.43, all P<0.001). Insulin secretion significantly predicted the Z-score independent of sex, body fat, blood lipids, blood pressure, IR, and glucose metabolism (P<0.005). CONCLUSION: β-cell dysfunction is highly correlated with the severity of metabolic syndrome in adults. Future work is warranted to elucidate the mechanism by which cardiometabolic disturbances influence insulin secretion.
Authors: Lori A Bateman; Cris A Slentz; Leslie H Willis; A Tamlyn Shields; Lucy W Piner; Connie W Bales; Joseph A Houmard; William E Kraus Journal: Am J Cardiol Date: 2011-07-07 Impact factor: 2.778
Authors: Thomas Pj Solomon; Jacob M Haus; Karen R Kelly; Marc D Cook; Julianne Filion; Michael Rocco; Sangeeta R Kashyap; Richard M Watanabe; Hope Barkoukis; John P Kirwan Journal: Am J Clin Nutr Date: 2010-10-27 Impact factor: 7.045
Authors: S M Haffner; R D'Agostino; M F Saad; M Rewers; L Mykkänen; J Selby; G Howard; P J Savage; R F Hamman; L E Wagenknecht Journal: Diabetes Date: 1996-06 Impact factor: 9.461
Authors: Johanna L Johnson; Cris A Slentz; Joseph A Houmard; Gregory P Samsa; Brian D Duscha; Lori B Aiken; Jennifer S McCartney; Charles J Tanner; William E Kraus Journal: Am J Cardiol Date: 2007-10-29 Impact factor: 2.778
Authors: Kristina M Utzschneider; Ronald L Prigeon; Mirjam V Faulenbach; Jenny Tong; Darcy B Carr; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Wilfred Y Fujimoto; Steven E Kahn Journal: Diabetes Care Date: 2008-10-28 Impact factor: 19.112
Authors: Steven K Malin; Emily L Kullman; Amanda R Scelsi; Jean-Philippe Godin; Alastair B Ross; John P Kirwan Journal: Mol Nutr Food Res Date: 2019-03-20 Impact factor: 5.914
Authors: Joyce S Ramos; Lance C Dalleck; Fabio Borrani; Alistair R Mallard; Bronwyn Clark; Shelley E Keating; Robert G Fassett; Jeff S Coombes Journal: Diabetologia Date: 2016-08-01 Impact factor: 10.122
Authors: Ciarán E Fealy; Stephan Nieuwoudt; Julie A Foucher; Amanda R Scelsi; Steven K Malin; Mangesh Pagadala; Lauren A Cruz; Miranda Li; Michael Rocco; Bartolome Burguera; John P Kirwan Journal: Exp Physiol Date: 2018-07 Impact factor: 2.969
Authors: John P Kirwan; Steven K Malin; Amanda R Scelsi; Emily L Kullman; Sankar D Navaneethan; Mangesh R Pagadala; Jacob M Haus; Julianne Filion; Jean-Philippe Godin; Sunil Kochhar; Alastair B Ross Journal: J Nutr Date: 2016-10-19 Impact factor: 4.798
Authors: Sapna S Shah; Claudia E Ramirez; Alvin C Powers; Chang Yu; Cyndya A Shibao; James M Luther Journal: Metabolism Date: 2016-02-26 Impact factor: 8.694
Authors: Steven K Malin; Sangeeta R Kashyap; Jeff Hammel; Yoshi Miyazaki; Ralph A DeFronzo; John P Kirwan Journal: Diabetes Care Date: 2014-08-19 Impact factor: 19.112
Authors: S K Malin; J Bena; B Abood; C E Pothier; D L Bhatt; S Nissen; S A Brethauer; P R Schauer; J P Kirwan; S R Kashyap Journal: Diabetes Obes Metab Date: 2014-09-14 Impact factor: 6.577
Authors: Brielle L Dotson; Emily M Heiston; Stephanie L Miller; Steven K Malin Journal: Am J Physiol Heart Circ Physiol Date: 2021-04-16 Impact factor: 5.125